This HTML5 document contains 119 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n16https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
schemahttp://schema.org/
dbthttp://dbpedia.org/resource/Template:
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n22http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
freebasehttp://rdf.freebase.com/ns/
n18http://www.grid.ac/institutes/
n14http://
n12http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Arena_Pharmaceuticals
rdf:type
dbo:Agent yago:Institution108053576 wikidata:Q24229398 yago:Organization108008335 dbo:Organisation yago:Abstraction100002137 yago:WikicatCompaniesInTheNASDAQBiotechnologyIndex yago:SocialGroup107950920 yago:WikicatCompaniesListedOnNASDAQ yago:WikicatBiotechnologyCompaniesOfTheUnitedStates owl:Thing dbo:Company yago:Company108058098 yago:YagoPermanentlyLocatedEntity yago:YagoLegalActor yago:YagoLegalActorGeo yago:Group100031264 yago:WikicatCompaniesBasedInSanDiego,California wikidata:Q4830453 wikidata:Q43229 schema:Organization n22:SocialPerson n22:Agent
rdfs:label
Arena Pharmaceuticals
rdfs:comment
Arena Pharmaceuticals, Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company's most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn's disease. In 2016, the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials. In December 2021, Pfizer announced that it had agreed to acquire Arena for $6.7 billion in cash. In March 2022, it was announced the acquisition by Pfizer had
foaf:name
Arena Pharmaceuticals
foaf:homepage
n14:www.arenapharm.com
dbp:name
Arena Pharmaceuticals
foaf:depiction
n12:ArenaLogo.jpg
dcterms:subject
dbc:Pharmaceutical_companies_established_in_1997 dbc:Health_care_companies_based_in_California dbc:Companies_formerly_listed_on_the_Nasdaq dbc:American_companies_established_in_1997 dbc:2022_mergers_and_acquisitions dbc:Biotechnology_companies_established_in_1997 dbc:Companies_based_in_San_Diego dbc:1997_establishments_in_California dbc:Pfizer dbc:Biotechnology_companies_of_the_United_States dbc:Pharmaceutical_companies_of_the_United_States dbc:Biopharmaceutical_companies
dbo:wikiPageID
21470125
dbo:wikiPageRevisionID
1114710542
dbo:wikiPageWikiLink
dbr:Nelotanserin dbc:Pharmaceutical_companies_established_in_1997 dbc:Biopharmaceutical_companies dbr:Ozanimod dbr:Celgene dbr:APD371 dbr:Eli_Lilly_and_Company dbr:Crohn's_disease dbc:Companies_formerly_listed_on_the_Nasdaq dbc:Companies_based_in_San_Diego dbc:Health_care_companies_based_in_California dbc:Biotechnology_companies_established_in_1997 dbr:San_Diego,_California dbc:American_companies_established_in_1997 dbr:Lorcaserin dbr:Autoimmune_disease dbr:Ulcerative_colitis dbc:2022_mergers_and_acquisitions dbr:Pfizer dbr:List_of_biotechnology_companies dbr:Taisho_Pharmaceutical_Co. dbr:U.S._Food_and_Drug_Administration dbr:Pulmonary_hypertension dbr:Etrasimod dbr:Subsidiary dbr:Thrombosis dbc:Pfizer dbc:Biotechnology_companies_of_the_United_States dbc:1997_establishments_in_California dbr:Pulmonary_Arterial_Hypertension dbc:Pharmaceutical_companies_of_the_United_States dbr:G_protein-coupled_receptors dbr:Biotechnology
dbo:wikiPageExternalLink
n14:www.arenapharm.com
owl:sameAs
yago-res:Arena_Pharmaceuticals wikidata:Q4788901 n16:4SUUG freebase:m.03p1j40
dbp:wikiPageUsesTemplate
dbt:Short_description dbt:Increase dbt:Url dbt:As_of dbt:Loss dbt:Profit dbt:Infobox_company dbt:Reflist
dbo:thumbnail
n12:ArenaLogo.jpg?width=300
dbp:assets
261M
dbp:equity
98.6M
dbp:founded
1997
dbp:industry
dbr:Biotechnology
dbp:keyPeople
Jack Lief, co-founder Kevin Lind, CFO Dominic Behan, co-founder and senior scientist Amit Munshi, CEO
dbp:locationCity
dbr:San_Diego,_California
dbp:locationCountry
U.S.
dbp:logo
ArenaLogo.jpg
dbp:netIncome
-85.5M
dbp:operatingIncome
-57M
dbp:products
Belviq
dbp:revenue
27.6M
dbp:type
Subsidiary of Pfizer
dbo:abstract
Arena Pharmaceuticals, Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company's most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn's disease. In 2016, the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials. In December 2021, Pfizer announced that it had agreed to acquire Arena for $6.7 billion in cash. In March 2022, it was announced the acquisition by Pfizer had been concluded.
skos:closeMatch
n18:grid.433329.c
prov:wasDerivedFrom
wikipedia-en:Arena_Pharmaceuticals?oldid=1114710542&ns=0
dbo:wikiPageLength
9434
dbo:foundingYear
1997-01-01
dbo:industry
dbr:Biotechnology
dbo:type
dbr:Subsidiary
foaf:isPrimaryTopicOf
wikipedia-en:Arena_Pharmaceuticals